Maldives vs Monaco: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Maldives
2.0%
in 2025
Monaco
0.0%
in 2025
Maldives rank
166th
Monaco rank
167th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Maldives
- Monaco
How they compare
Maldives currently reports 2.0% against 0.0% in Monaco, a difference of 2.0%.
The two have swapped places 1 time across 18 shared years of data; in 2008 it was Monaco ahead.
Maldives ranks 166th and Monaco ranks 167th of 194 countries.
Maldives has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Maldives | Monaco | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 0.0% | 0.0% | 0.0% | — |
| 2020s | 0.3% | 0.0% | 0.3% | Maldives |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Maldives or Monaco?
- Maldives, at 2.0% against 0.0% in Monaco as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Maldives and Monaco?
- 2.0%, with Maldives ahead.
- How many years of comparable data are there for Maldives and Monaco?
- 18 years are reported by both, from 2008 to 2025.
- How do Maldives and Monaco rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Maldives ranks 166th and Monaco ranks 167th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.